Response to ASX Query Letter
Filed with ASX · · 5 pages · English
Vectus Biosystems Limited on 6ix
Earlier from Vectus Biosystems
- Reinstatement to Quotation
- VB4-P5 Renal Compound Transaction
- Suspension from Quotation
- Trading Halt
- Pause in Trading
Later from Vectus Biosystems
- Quarterly Activities & Appendix 4C Cash Flow Reports
- Half Year Report & Appendix 4D
- VB4-P5 Renal Compound Transaction Settled
- Appointment of Dr Tara Speranza as CEO & CTO
- Placement of Shares
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems